Главная »» Science articles of world periodical [1998 - 2003] »» O »» Oncol Rep
версия для печати
Takenoshita S. Mogi A. Osawa H. Sunaga H. Kakegawa H. Tani M. Morinaga N. Kato R. Hagiwara K. Nagamachi Y.
First Department of Surgery, Gunma University School of Medicine, 3-39-22, Showamachi, Maebashi, Gunma, 371, Japan.
Mutations in the transforming growth factor beta type II receptor (TGFbetaRII) gene have been detected in several human cancers that represent the phenotype of genomic instability. To establish a basis for diagnosis of cancer patients, we previously determined the exon-intron organization of the TGFbetaRII gene. The results indicated that TGFbetaRII protein is encoded by 567 codons in 7 exons. In this study, we further determined the nucleotide sequences surrounding these 7 exons and designed 8 sets of intron-based primers to examine the entire coding region of the TGFbetaRII gene. By using these primers, we screened for mutations of the TGFbetaRII gene in DNAs of 32 sporadic gastric cancer patients in whom one case showed MI+ (3.1%) at two loci. We found no mutations, and these data support other recent evidence that TGFbetaRII mutations rarely occur except in colon and gastric tumors with MI.